Lijie He

1.1k total citations
21 papers, 709 citations indexed

About

Lijie He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lijie He has authored 21 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Lijie He's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (3 papers). Lijie He is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (3 papers). Lijie He collaborates with scholars based in China, Germany and Australia. Lijie He's co-authors include Wei‐Hua Chen, Xing‐Ming Zhao, Changcun Guo, Kaichun Wu, Daiming Fan, Xiaodi Zhao, Yongzhan Nie, Chuqing Sun, Sicheng Wu and Die Dai and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Lijie He

21 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijie He China 12 502 220 106 74 65 21 709
Shuo Zeng China 10 608 1.2× 274 1.2× 110 1.0× 55 0.7× 97 1.5× 13 797
Xinyu Shao China 11 333 0.7× 122 0.6× 179 1.7× 70 0.9× 83 1.3× 29 585
Yue He China 14 444 0.9× 299 1.4× 43 0.4× 84 1.1× 50 0.8× 23 712
Haixiang Sun China 14 441 0.9× 251 1.1× 164 1.5× 75 1.0× 41 0.6× 24 705
Martina Klünemann Germany 5 446 0.9× 111 0.5× 126 1.2× 91 1.2× 28 0.4× 9 687
Linhua Ji China 13 296 0.6× 150 0.7× 88 0.8× 53 0.7× 40 0.6× 35 500
Zhonghua Chu China 17 461 0.9× 182 0.8× 227 2.1× 69 0.9× 66 1.0× 36 759
Ling Fu China 11 364 0.7× 114 0.5× 141 1.3× 58 0.8× 55 0.8× 19 715
Ruxian Lin United States 16 407 0.8× 118 0.5× 91 0.9× 97 1.3× 96 1.5× 40 722
Yasi Pan Hong Kong 11 665 1.3× 310 1.4× 205 1.9× 89 1.2× 104 1.6× 18 993

Countries citing papers authored by Lijie He

Since Specialization
Citations

This map shows the geographic impact of Lijie He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie He more than expected).

Fields of papers citing papers by Lijie He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijie He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie He. The network helps show where Lijie He may publish in the future.

Co-authorship network of co-authors of Lijie He

This figure shows the co-authorship network connecting the top 25 collaborators of Lijie He. A scholar is included among the top collaborators of Lijie He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijie He. Lijie He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jipeng, et al.. (2025). Immunomodulatory effects of mesenchymal stem cell therapy in chronic kidney disease: a literature review. BMC Nephrology. 26(1). 107–107. 3 indexed citations
2.
Lv, Dongqing, Jiuwei Cui, Zhen Wang, et al.. (2024). A phase Ib/IIa trial to evaluate the safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced NSCLC.. Journal of Clinical Oncology. 42(16_suppl). 8533–8533. 5 indexed citations
3.
Xu, Yaolin, et al.. (2021). Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints. Frontiers in Oncology. 11. 759015–759015. 28 indexed citations
4.
Ning, Jing, Shenyi Jiang, Xiaoxi Li, et al.. (2021). GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. BMC Pulmonary Medicine. 21(1). 199–199. 13 indexed citations
5.
Dai, Die, Chuqing Sun, Min Li, et al.. (2021). GMrepo v2: a curated human gut microbiome database with special focus on disease markers and cross-dataset comparison. Nucleic Acids Research. 50(D1). D777–D784. 100 indexed citations
6.
Hao, Xiaowen, Túlio de Lima Campos, Neil D. Young, et al.. (2020). OGEE v3: Online GEne Essentiality database with increased coverage of organisms and human cell lines. Nucleic Acids Research. 49(D1). D998–D1003. 53 indexed citations
7.
Li, Hongshi, Ning Wei, Yi Ma, et al.. (2020). Integrative module analysis of HCC gene expression landscapes. Experimental and Therapeutic Medicine. 19(3). 1779–1788. 4 indexed citations
8.
Xu, Lu, Lijie He, Jin Wang, et al.. (2020). MiR-891a-5p as a prognostic marker and therapeutic target for hormone receptor-positive breast cancer. Journal of Cancer. 11(13). 3771–3782. 20 indexed citations
9.
10.
Hu, Jinping, Huan Li, Xiujuan Tian, et al.. (2020). Red blood cell distribution width and peritoneal dialysis-associated peritonitis prognosis. Renal Failure. 42(1). 613–621. 7 indexed citations
11.
Hao, Dapeng, Guangyu Wang, Weiwei Yang, et al.. (2019). Reactive versus Constitutive: Reconcile the Controversial Results about the Prognostic Value of PD-L1 Expression in cancer. International Journal of Biological Sciences. 15(9). 1933–1941. 2 indexed citations
12.
13.
Ma, Yi, Lijie He, Shuang Zheng, et al.. (2018). Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report. BMC Medical Genetics. 19(1). 185–185. 5 indexed citations
14.
Li, Baoyu, Lijie He, & Hui Liu. (2018). Down-regulation of LINC00341 predicts a poor prognosis and acts as a tumor suppressor in gastric cancer.. PubMed. 11(8). 4205–4212. 2 indexed citations
15.
He, Lijie, et al.. (2018). High expression of RAB38 promotes malignant progression of pancreatic cancer. Molecular Medicine Reports. 19(2). 909–918. 11 indexed citations
16.
Bai, Ming, Yan Yu, Chen Huang, et al.. (2016). Continuous venovenous hemofiltration combined with hemoperfusion for toxic epidermal necrolysis: a retrospective cohort study. Journal of Dermatological Treatment. 28(4). 353–359. 5 indexed citations
17.
Sun, Shiren, Lijie He, Ming Bai, et al.. (2015). High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study. Annals of Saudi Medicine. 35(5). 352–358. 31 indexed citations
18.
Zhao, Xiaodi, Lijie He, Yuanyuan Lu, et al.. (2014). SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer. Cell Death and Differentiation. 21(12). 1900–1913. 84 indexed citations
19.
Liang, Shuli, Lijie He, Xiaodi Zhao, et al.. (2011). MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer. PLoS ONE. 6(4). e18409–e18409. 155 indexed citations
20.
Jin, Haifeng, Yanglin Pan, Lijie He, et al.. (2007). p75 Neurotrophin Receptor Inhibits Invasion and Metastasis of Gastric Cancer. Molecular Cancer Research. 5(5). 423–433. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuo Zeng Breakdown of academic impact, for papers by Xinyu Shao Breakdown of academic impact, for papers by Yue He Breakdown of academic impact, for papers by Haixiang Sun Breakdown of academic impact, for papers by Martina Klünemann Breakdown of academic impact, for papers by Linhua Ji Breakdown of academic impact, for papers by Zhonghua Chu Breakdown of academic impact, for papers by Ling Fu Breakdown of academic impact, for papers by Ruxian Lin Breakdown of academic impact, for papers by Yasi Pan
Rankless by CCL
2026